| 7471LI |
1-(3-chlorophenyl)piperazine (mCPP) Identification, Liquid |
| 7471SL |
1-(3-chlorophenyl)piperazine (mCPP) Identification, Solid |
| 7466LI |
1-(3-Trifluoromethylphenyl) piperazine (TFMPP) Identification, Liquid |
| 7466SL |
1-(3-Trifluoromethylphenyl) piperazine (TFMPP) Identification, Solid |
| 7467LI |
2,5-Dimethoxy-4(n)-propylthiophenethylamine (2C-T-7) Identification, Liquid |
| 7467SL |
2,5-Dimethoxy-4(n)-propylthiophenethylamine (2C-T-7) Identification, Solid |
| 7468LI |
4-bromo-2,5-dimethoxyphenethylamine (2C-B) Identification, Liquid |
| 7468SL |
4-bromo-2,5-dimethoxyphenethylamine (2C-B) Identification, Solid |
| 7204LI |
4-Methylmethcathinone Identification, Liquid |
| 7204SL |
4-Methylmethcathinone Identification, Solid |
| 7463LI |
Alpha-methyltryptamine (AMT) Identification, Liquid |
| 7463SL |
Alpha-methyltryptamine (AMT) Identification, Solid |
| 7465LI |
Benzylpiperazine Identification, Liquid |
| 7465SL |
Benzylpiperazine Identification, Solid |
| 7473SL |
Comprehensive Drug Panel including Synthetic Cannabinoids and Designer Drugs, Solid |
| 7210LI |
Comprehensive Stimulants and Hallucinogens Panel, Liquid |
| 7210SL |
Comprehensive Stimulants and Hallucinogens Panel, Solid |
| 7201LI |
Controlled Substances and Pharmaceuticals Panel, Liquid |
| 7201SL |
Controlled Substances and Pharmaceuticals Panel, Solid |
| 7464LI |
Dimethyltryptamine (DMT) Identification, Liquid |
| 7464SL |
Dimethyltryptamine (DMT) Identification, Solid |
| 7082LI |
Dosage Form Identification and Quantitation by LC-MS/MS, Liquid |
| 7082SL |
Dosage Form Identification and Quantitation by LC-MS/MS, Solid |
| 7080LI |
Dosage Form Identification and Quantitation, Liquid |
| 7080SL |
Dosage Form Identification and Quantitation, Solid |
| 6464LI |
Dosage Form Quantitation, Liquid |
| 6464SL |
Dosage Form Quantitation, Solid |
| 6466LI |
Drug Identification and Quantitation, Liquid |
| 6466SL |
Drug Identification and Quantitation, Solid |
| 7475LI |
Federally Scheduled Synthetic Cannabinoids, Liquid |
| 7475SL |
Federally Scheduled Synthetic Cannabinoids, Solid |
| 7097SL |
Forensic Examination/Processing (Hourly Rate) |
| 6210LI |
General Unknown Panel, Liquid |
| 6210SL |
General Unknown Panel, Solid |
| 7084LI |
LC-MS/MS Identification, Liquid |
| 7084SL |
LC-MS/MS Identification, Solid |
| 7470LI |
Milnacipran Identification, Liquid |
| 7470SL |
Milnacipran Identification, Solid |
| 7461LI |
Salvinorin A Identification, Liquid |
| 7461SL |
Salvinorin A Identification, Solid |
| 7462LI |
Sibutramine Identification, Liquid |
| 7462SL |
Sibutramine Identification, Solid |
| 7472SL |
Synthetic Cannabinoids Investigation, Solid |
| 7469LI |
Tapentadol Identification, Liquid |
| 7469SL |
Tapentadol Identification, Solid |